The Discounted Cash Flow (DCF) valuation of EZZ Life Science Holdings Ltd (EZZ.AX) is 4.54 AUD. With the latest stock price at 1.60 AUD, the upside of EZZ Life Science Holdings Ltd based on DCF is 184.1%.
Based on the latest price of 1.60 AUD and our DCF valuation, EZZ Life Science Holdings Ltd (EZZ.AX) is a buy. buying EZZ.AX stocks now will result in a potential gain of 184.1%.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.9% | 6.8% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 3.74 - 5.88 | 4.54 |
| Upside | 133.9% - 267.6% | 184.1% |